English
|
Spanish
Supporting oncology professionals through education
Login
Register
The content on this site is intended for healthcare professionals only
Menu
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
News
Latest news
Sign up for news alerts
Submit your news
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Journal information
Journal home
Charges
Editorial board
Founding editors
Editor-in-chief
Contact us
Author information
Submit article
Author guidelines
Editorial policies
Copyright information
Why publish with us
Reviewer information
Reviewer guidelines
Memberships
Videos
Recent videos
Sign up
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Conferences
Latest conferences
Sign up for latest coverage
Submit your event
About
e
cancer
About
e
cancer
Our founders
Funding statement
Contact us
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
+
-
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
How azacitidine works
Share :
ASH 50th annual meeting 2008
Please rate this video
The information in this video was of interest to me
The information in this video is likely to improve my clinical practice or research
I would recommend this video to my colleagues
Published:
19 Feb 2009
Views:
21226
Rating:
Save
Rate video
Dr Lewis Silverman - Myelodysplastic Syndrome & Myeloproliferative Disease Center, New York
How azacitidine / vidaza works, epigenetics and vidaza, the difference vidaza makes for patients. Interviewed at ASH 2008.
Categories:
Haematology oncology
Biology
Drug development
Related Videos
Linvoseltamab induces deep and durable responses in patients with relapsed or...
Dr Sundar Jagannath - Icahn School of Medicine at Mount Sinai, New York, USA
24 Apr 2024
Multiple myeloma in a resource constrained setting
Dr Henry Ddungu - Uganda Cancer Institute, Kampala, Uganda
22 Feb 2024
Multiple myeloma treatment in Dakar: Epidemiological, diagnostic, and...
Dr Nata Dieng - Hôpital Principal de Dakar, Dakar, Senegal
25 Jan 2024
Ide-cell enhances health-related quality of life for refractory multiple myeloma
Dr Michel Delforge - University Hospital Leuven, Leuven, Belgium
24 Dec 2023
Adding nivolumab to R-GemOx shows enhanced efficacy in treating R/R large B...
Dr Gerhard Held - Westpfalz-Klinikum, Kaiserslautern, Germany
20 Dec 2023
Ponatinib is superior to imatinib in combination with chemotherapy for newly...
Dr Elias Jabbour - MD Anderson Cancer Center, Houston, USA
19 Dec 2023
Relapsed Refractory Multiple Myeloma
Dr Hari Menon - St. Johns National Academy of Health Sciences, Bengaluru, India
5 Dec 2023
Epitope editing enables targeted immunotherapy of acute myeloid leukaemia
Dr Gabriele Casirati - Dana-Farber Cancer Institute, Boston, USA
3 Oct 2023
Real-world use of brexu-cel shows benefit in R/R mantle cell lymphoma treatment
Dr Nausheen Ahmed - The University of Kansas Cancer, Kansas, USA
23 Jun 2023
More from
e
cancer